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Abstract Rheumatoid arthritis (RA) is an autoimmune
disease characterized by chronic inﬂammation. It has been
suggested that the level of reactive oxygen species (ROS)
in patients with RA is higher than in healthy subjects. The
aim of the present study was to investigate the level of the
lipid peroxidation, antioxidant enzyme activities (CAT,
SOD, GSH-Px), level of the –SH groups and GSH and
Na
?K
? ATPase activity in erythrocytes from patients with
RA. There are no signiﬁcant differences in CAT and GSH-
Px activities. SOD activity is lower in RA patients than in
the control group. Increase in the lipid peroxidation is
observed in RA patients. Levels of the GHS and –SH
groups are signiﬁcantly lower in RA patients than in the
control groups. Total ATPase and Na
?K
? ATPase activi-
ties decrease in RA patients.
Keywords Rheumatoid arthritis  Lipid peroxidation 
Antioxidant enzymes  Thiol groups  Na
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Introduction
Rheumatoid arthritis is an autoimmune disease where
diagnosis is based on clinical and radiological features and
presence of rheumatoid factor in serum. It is characterized
by chronic inﬂammation leading to joints’ destruction. The
pathogenesis of RA is not fully understood yet. RA is not
generally recognized as a disease of oxidative stress but it
has been suggested that the level of reactive oxygen species
(ROS) in patients with RA is higher than in healthy sub-
jects. Oxidative stress in RA is due to the fact that the
antioxidant systems are impaired [1, 2].
The aim of this paper is to study the antioxidant system
in erythrocyte from patients with RA. The increase in ROS
leads to signiﬁcant changes in the structure of membrane
lipids and proteins that may impair membrane functions
and inﬂuence the antioxidant enzymes activity.
Patients and methods
Patients
The study plan was approved by the Medical Ethic Com-
mittee RNN/42/06/KB. All subjects were volunteers.
Fasting blood samples were obtained from 25 RA patients
(21 women and 4 men) and 35 control subjects. RA
patients were diagnosed according to the criteria for the
classiﬁcation of rheumatoid arthritis of American Rheu-
matism Association [3].
Methods
Erythrocytes
Blood was obtained by venipuncture. ACD (23 mM citric
acid, 45.1 mM sodium citrate, 45 mM glucose) was used
as an anticoagulator. Blood samples were centrifuged at
3,000g for 10 min at 4C to separate plasma and red
blood cells. Erythrocytes were washed three times with
0.9% NaCl. The haematocrit of the ﬁnal red blood cell
suspensions was made up to 50%. The haemoglobin
concentration was determined with the aid of the Drab-
kin’s reagent [4].
A. Staron ´ (&)  G. Ma ˛kosa  M. Koter-Michalak
University of Lodz, Lodz, Poland
e-mail: agnieszka.staron1@wp.pl
123
Rheumatol Int (2012) 32:331–334
DOI 10.1007/s00296-010-1611-2Erythrocytes membrane
The erythrocytes membranes were prepared by the Dodge’s
method [5] with a modiﬁcation of Tris buffer (pH 7.4). The
protein concentration in the membrane was estimated by
the use of the Lowry test [6].
Peroxidation of lipids
The TBARs assay was used for measuring the peroxidation
intensity. This is based on the reaction of TBA (thiobar-
bituric acid) with the end product of lipid peroxidation–
malondialdehyde [7]. Level of the lipid peroxidation was
measured in whole red cells.
Measurement of –SH group
The concentration of –SH groups was measured by Ell-
man’s method [8]. The membrane suspension was mixed
with 10% SDS and H2O and that mixture was incubated in
phosphate buffer with the solution of DTNB in sodium
citrate. After 30-min incubation, the spectrophotometric
absorption was measured at 412 nm.
Level of the GHS
The level of the GSH was measured by Ellman’s method
[8]. The suspension of red blood cells (Ht 2%) was incu-
bated with DTNB for 20 min in dark. The spectrophoto-
metric absorption was measured at 412 nm.
Measurement of Na
?K
? ATPase activity
Na
?K
? ATPase activity was measured by Bartosz’s
method [9]. This method is based on the measurement of
orthophosphate released from ATP during incubation of
membranes with a medium containing: 1 mM ATP,
10 mM MgCl2, 100 mM Tris–HCl buffer (pH 7.4) and
0.1 mM ouabain, which is added to block the Na
?K
?
ATPase. Samples were incubated for 30 min in 37C and
in 0C. After the incubation, 0.6 M TCA was added.
Concentration of the orthophosphate was determined in the
supernatant by the Veldhoven and Mannaers’s method
(1987).
SOD activity
Thismethodisbasedonreactionautooxidationadrenalineto
adenochrome. The intermediate in this reaction is superox-
ide, which is scavenged by SOD. One SOD unit was deﬁned
astheenzymeamountcausing50%inhibitionautooxidation
of adrenaline. SOD activity was also expressed as units per
gram of haemoglobin [U/gHb][ 10, 11].
CAT activity
CAT activity was measured by Aebi’s method [12]. It is
based on scavenging hydrogen peroxide by CAT. The
decrease in absorbance is measured at 240 nm. One CAT
unit was deﬁned as the enzyme’s amount scavenging
1 lmol H2O2 in one minute. CAT activity was also
expressed as units per milligram of haemoglobin [U/mgHb].
GSH-Px activity
Measurement of GSH-Px activity was based on the fol-
lowing principle: GSH-Px catalyses the oxidation of glu-
tathione by cumene hydroperoxide. In the presence of
glutathione reductase and nicotinamide adenine dinucleo-
tide phosphate (NADPH), the oxidized glutathione is
immediately converted to the reduced form with a con-
comitant oxidation of NADPH to NADP
?. The decrease in
absorbance is measured at 340 nm. Erythrocyte GSH-Px
activity was expressed as units per gram of haemoglobin
[U/gHb][ 13].
Statistical analysis
Data were expressed as mean values ± S.E.M of measured
parameters. The Student’s test was used to estimate the
differences between groups.
Results
Level of the lipid peroxidation is shown in Table 1. Con-
centration of TBARs [lmol MDA/gHb] in the erythrocyte
membranes from the RA was determined and compared to
the control group. It was signiﬁcantly higher in RA patients
than in healthy individuals.
The plasma membrane protein damage was determined
by total ATPase and Na
?K
? ATPase activities and con-
centration of –SH groups (Table 2). The level of the total
ATPase was about 10% higher, and the level of the Na
?K
?
ATPase was about 20% higher in the control group than
in RA patients. These differences were statistically sig-
niﬁcant. The –SH groups’ concentration in the erythrocyte
Table 1 Level of the TBARs [lmol MDA/gHb] in RA patients and
the control group
TBARs [lmol MDA/gHb]
RA 0.336 ± 0.11 (n = 20)
Control group 0.288 ± 0.04 (n = 24)
P \0.05
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lower than in healthy individuals.
Antioxidant enzymes activities and concentration of
GHS are given in Table 3. SOD activity is signiﬁcantly
lower in RA patients than in control group (P\0.005).
There are no signiﬁcant differences in CAT and GSH-Px
activities. Concentration of the GSH is about 20% lower in
RA patients than in healthy subjects.
Discussion
Imbalance in the human oxidative/antioxidative status
leads to oxidative stress, which is involved in ageing and
number of disorders: vascular diseases (e.g. atherosclero-
sis, stroke, reperfusion damage), neurodegenerative dis-
eases (e.g. Parkinson’s, Alzheimer’s, multiple sclerosis),
lung diseases (e.g. pneumonia), eye diseases (e.g. cataract,
retinopathy), autoimmune diseases (e.g. rheumatoid
arthritis) [14–17]. The result of the present study showed
that oxidative stress in RA patients is higher than in control
group. Similar conclusion is presented in another studies,
e.g. Altindag et al. [18] stated higher oxidative stress on the
basis of increasing oxidative DNA damage.
In RA, damage to the plasma membranes of red blood
cells is observed. This may result from the peroxidation of
polyunsaturated fatty acids and changes in proteins. It is
known that MDA, which is one of the ﬁnal products of
lipid peroxidation, could cause erythrocytes plasma mem-
brane stiffness. It impairs the cells ability to change shape.
Phosphatidyloserine movement from the inner to the outer
layer under the inﬂuence of free radicals affects the losing
of membrane ﬂuidity.
Level of the lipid peroxidation is signiﬁcantly higher in
the patients with RA than in the control group and it is in
agreement with most studies [19, 20]. On the basis of the
obtained results and the literature data, it can be concluded
that in RA, red blood cells are more susceptible to the
inﬂuence of free radicals.
Thiol groups play an important role in a variety of
activities of cell membranes. As described by Deuticke
[21], membrane thiol groups are liable to be modiﬁed by
oxidants or alkylating agents. Oxidation of thiol groups of
erythrocyte membrane can increase their permeability to
ions such as K
?,N a
? and Ca
?, indicating that membrane
permeability to these ions is correlated with membrane
thiol groups.
Free radicals’ processes lead to lipid peroxidation and
decreased concentration of –SH groups in membrane pro-
teins. Our data illustrate the decrease in the concentration
of thiol groups about 30%. A decrease in the accessible
–SH groups should be correlated with increased aggrega-
tion of membrane proteins since a signiﬁcant fraction of the
oxidized groups can be involved in the formation of the
disulphide bridges [22].
Na
?K
?-ATPase is the membrane lipid–protein com-
plex. It contains 30% lipids, most of them are phosphate
lipids and cholesterol. It produces energy by hydrolysing
ATP and transports ions for keeping the stable ion content
which is needed for normal physiological activity [23, 24].
Total ATPase and Na
?K
? ATPase activities were lower in
RA patients than in the control groups. It is in agreement
with another data that indicate inhibitory inﬂuence of free
radicals on ATPase activity [25, 26].
Antioxidant enzymes are responsible for defence against
free radicals. There are some reports on erythrocyte SOD,
CAT and GSH-Px activities in patients with RA, but the
results are controversial. In the present study, inhibition of
the SOD activity was observed. Sarban [19] observed no
changes, and Akyol [20] noticed no change in erythrocytes
SOD and inhibition of plasma SOD. Cimen [27] observed
increase in erythrocyte SOD activity. In the present study,
Table 2 Total ATPase and Na
?K
?ATPase activities [nmol P/mgp*h] and concentration of the –SH groups [nmol SH/mgp] in RA patients and
control group
Total ATPase Na
?K
?ATPase –SH
RA 458.65 ± 146.96 (n = 24) 230.06 ± 94.89 (n = 22) 0.041 ± 0.012 (n = 7)
Control group 536.54 ± 180.79 (n = 29) 279.76 ± 98.14 (n = 29) 0.059 ± 0.022 (n = 30)
P \0.05 \0.05 \0.001
Table 3 Antioxidant enzymes activities and concentration of the GSH [lmol/mlpc] in RA patients and in the control group
CAT [U/mg Hb] SOD [U/mg Hb] GSH-Px [U/g Hb] GSH [lmol/mlpc]
RA 272.62 ± 63.55 (n = 21) 2036.52 ± 438.44 (n = 20) 19.45 ± 6.69 (n = 22) 0.961 ± 0.23 (n = 10)
Control group 263.44 ± 40.97 (n = 30) 3146.55 ± 727.45 (n = 17) 18.14 ± 7.17 (n = 35) 1.154 ± 0.33 (n = 17)
P NS \0.005 NS \0.05
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123signiﬁcant differences in CAT and GSH-Px activities were
not noticed and it is in agreement with most of studies but
there are some differences between researchers too—Sar-
ban observed inhibition of CAT and GSH-Px activities. His
results conﬁrm increase in oxidative stress in RA patients.
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